Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alfred Mertens is active.

Publication


Featured researches published by Alfred Mertens.


Virchows Archiv | 2012

Systematic comparison of tissue fixation with alternative fixatives to conventional tissue fixation with buffered formalin in a xenograft-based model

Thorben Nietner; Tiantom Jarutat; Alfred Mertens

In our study we systematically compared the alternative fixatives acidified formal alcohol (AFA), PAXgene®, HOPE®, and combinations of AFA or formalin with ultrasound treatment to standard (buffered) formalin fixation. We examined general morphology and detectability of protein structures by immunohistochemistry of the membrane receptors epidermal growth factor receptor (EGFR), insulin-like growth factor 1 receptor (IGF-1R), and phosphorylated human epidermal growth factor receptor 2 (phospho-HER2). In order to allow for stringent comparability of different fixation techniques, we used matched mouse xenograft tumor samples from three different human cancer cell lines (colon, ovarian, and non-small cell lung cancer), either fixed conventionally with formalin or an alternative fixative. Tissue morphology after fixation with AFA and PAXgene® was comparable to formalin-fixed paraffin-embedded tissue (FFPET) morphology. Ultrasound fixations resulted in slightly inferior morphology and HOPE® fixation preserved morphology only poorly compared to FFPET in this system. None of the tested alternative fixatives enabled immunohistochemical detectability of all three targets in the same manner as FFPET. Pronounced staining was possible for EGFR and IGF-1R with all alternative fixatives but HOPE®, and phospho-HER2 staining was only noteworthy with formalin-ultrasound-fixed tissue. Therefore, the use of alternative fixatives comes with the need for careful validation of obtained IHC results individually for each target.


Virchows Archiv | 2013

Reply to the comment of Drs Goldman and Vollmer

Thorben Nietner; Tiantom Jarutat; Alfred Mertens

Dear Editor, We appreciate dear Drs Goldman and Vollmers reaction to our paper [1]. Indeed, the results with HOPE were somewhat surprising to us, and hence, we made every effort to follow the manufacturers instructions as closely as possible in repeated attempts, before including the results in the manuscript. As detailed in Supplementary file 1 (http://www. ncbi.nlm.nih.gov/pmc/articles/PMC3432218/bin/428_ 2012_1248_MOESM1_ESM.pdf), the fixation process and the deparaffinization procedure were both carried out according to the manual referenced in the reply letter (i.e. the manufacturers instructions). Our study investigated the H&E staining morphology and results of IHC assays obtained with tissues that underwent alternative fixation techniques in comparison with the standard formalin fixation, knowing (and that was discussed in the paper) that the stains/assays were originally optimized for formalin-fixed paraffin-embedded tissues. Yet, for HOPE, we not only took care of the correct fixation, dehydration and deparaffinization process as instructed but we also individually optimized the immunohistochemical staining protocol to use, e.g. the recommended citrate buffer (Ventanas CC2 buffer, ref. Supplementary file 3: http://www.ncbi.nlm. nih.gov/pmc/articles/PMC3432218/bin/428_2012_1248_ MOESM3_ESM.pdf) for antigen unmasking in order to compare the strongest achievable signal for each fixative we tested. In addition to our results, other investigators also reported histomorphological alterations attributable to the HOPE fixation process, such as “...the HOPE fixed samples generally exhibited a slightly diminished quality of structure. In some of the latter sections, a separation of the epithelium and the underlying lamina propia was observed, additionally, in some cases the epithelium had rolled up. [...] After histological staining, HOPE-fixed tissue often also displayed shrinkage artefacts...” [2]. Likewise, “...HOPE fixative led to a loosened tissue structure and a swollen appearance. The H&E process following HOPE fixation did not result in well-stained samples even after optimization of the staining process[...] HOPE fixative dramatically altered the macroscopic appearance of the tissue-engineered constructs. H&E staining of HOPE-fixed constructs also revealed distinct changes in overall tissue structure that rendered them impractical for further morphological analysis.” [3]. We remain convinced that we included the HOPE technique into our study in an adequate manner, making sure that the instructions specific for the HOPE process were followed correctly without compromising the overall comparability with other methods. Thus, we still regard the results obtained and presented in the paper as valid.


Archive | 1995

New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs

Dieter Herrmann; Hans-Georg Opitz; Harald Zilch; Alfred Mertens


Archive | 2006

Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer

Li Chen; Guy Georges; Alfred Mertens; Xihan Wu


Archive | 2006

Isoquinoline aminopyrazole derivatives

Li Chen; Guy Georges; Alfred Mertens; Xihan Wu


Archive | 1994

New thiazolidindiones and drugs containing them

Alfred Mertens; Hans-Peter Dipl Chem Dr Wolff; Peter Freund


Chemistry & Biology | 2014

Development of Bispecific Molecules for the In Situ Detection of Protein-Protein Interactions and Protein Phosphorylation

Jan van Dieck; Volker Schmid; Dieter Heindl; Sebastian Dziadek; Michael Schraeml; Michael Gerg; Petra Massoner; Alfred Engel; Georg Tiefenthaler; Serhat Vural; Simon Stritt; Fabian Tetzlaff; Monika Soukupova; Erhard Kopetzki; Birgit Bossenmaier; Marlene Thomas; Christian Klein; Alfred Mertens; Astrid Heller; Michael Tacke


Archive | 2011

DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT

Michael Gerg; Dieter Heindl; Alfred Mertens; Christoph Rutz; Michael Schraeml; Monika Soukupova; Claudio Sustmann; Michael Tacke; Dieck Jan Van


Archive | 1996

New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds

Christos Dipl Chem Tsaklakidis; Alfred Mertens; Gerd Zimmermann; Wolfgang Schäfer; Liesel Dörge


Archive | 2011

Erkennung von posttranslational modifiziertem polypeptid durch ein bivalentes bindungsmolekül

Michael Gerg; Dieter Heindl; Christian Klein; Alfred Mertens; Volker Schmid; Michael Schraeml; Monika Soukupova; Michael Tacke

Collaboration


Dive into the Alfred Mertens's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge